Effectiveness of Moderna’s mRNA-1345 RSV vaccine (mRESVIA) in the prevention of respiratory syncytial (RSV) among adults in Kaiser Permanente Northern California (KPNC)

This study will expand the understanding of mRESVIAs impact in real-world older adult populations by examining the prevention of medically attended and other outcomes related to respiratory syncytial virus (RSV) among adults 60 years at Kaiser Permanente Northern California (KPNC).

0